![Imperial and Crick cancer drug spinout raises £90m to begin clinical development](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1720107681195_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
Strong medicine
Imperial and Crick cancer drug spinout raises £90m to begin clinical development
Myricx Bio is bringing new therapeutic possibilities to the highly promising area of antibody-drug conjugates for treating cancer.